-transparent.png){kind=logo}
The pharmacokinetics of misonidazole, a hypoxic-cell radiosensitizer, were determinated after intraperitoneal administration to standardized Balb/c mice. The experimental data was fitted, using non linear analysis, to plasma-concentration curves described by tri-exponential equations derived from a two-compartment model. The pharmacokinetic constants (absorption and elimination coefficients) were determinated.
Related Publications
M F Malmary-Nebot, and
C Labat, and
M Terrissol, and
B Martin, and
J Oustrin
February 1983,
Cancer research,
M F Malmary-Nebot, and
C Labat, and
M Terrissol, and
B Martin, and
J Oustrin
January 1981,
Cancer chemotherapy and pharmacology,
M F Malmary-Nebot, and
C Labat, and
M Terrissol, and
B Martin, and
J Oustrin
January 1980,
Strahlentherapie,
M F Malmary-Nebot, and
C Labat, and
M Terrissol, and
B Martin, and
J Oustrin
March 1991,
Archiv der Pharmazie,
M F Malmary-Nebot, and
C Labat, and
M Terrissol, and
B Martin, and
J Oustrin
January 1981,
Farmakologiia i toksikologiia,
M F Malmary-Nebot, and
C Labat, and
M Terrissol, and
B Martin, and
J Oustrin
January 1988,
Cancer chemotherapy and pharmacology,
M F Malmary-Nebot, and
C Labat, and
M Terrissol, and
B Martin, and
J Oustrin
October 2004,
Drug metabolism and disposition: the biological fate of chemicals,
M F Malmary-Nebot, and
C Labat, and
M Terrissol, and
B Martin, and
J Oustrin
January 1992,
Cancer chemotherapy and pharmacology,
M F Malmary-Nebot, and
C Labat, and
M Terrissol, and
B Martin, and
J Oustrin
January 1985,
Drugs under experimental and clinical research,
M F Malmary-Nebot, and
C Labat, and
M Terrissol, and
B Martin, and
J Oustrin
June 2016,
American journal of veterinary research,
